1. Home
  2. OLMA vs ESE Comparison

OLMA vs ESE Comparison

Compare OLMA & ESE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • ESE
  • Stock Information
  • Founded
  • OLMA 2006
  • ESE 1990
  • Country
  • OLMA United States
  • ESE United States
  • Employees
  • OLMA N/A
  • ESE N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • ESE Telecommunications Equipment
  • Sector
  • OLMA Health Care
  • ESE Telecommunications
  • Exchange
  • OLMA Nasdaq
  • ESE Nasdaq
  • Market Cap
  • OLMA 465.4M
  • ESE 3.5B
  • IPO Year
  • OLMA 2020
  • ESE N/A
  • Fundamental
  • Price
  • OLMA $5.75
  • ESE $134.22
  • Analyst Decision
  • OLMA Strong Buy
  • ESE Buy
  • Analyst Count
  • OLMA 5
  • ESE 3
  • Target Price
  • OLMA $26.25
  • ESE $137.67
  • AVG Volume (30 Days)
  • OLMA 1.1M
  • ESE 89.5K
  • Earning Date
  • OLMA 11-12-2024
  • ESE 02-06-2025
  • Dividend Yield
  • OLMA N/A
  • ESE 0.24%
  • EPS Growth
  • OLMA N/A
  • ESE 10.06
  • EPS
  • OLMA N/A
  • ESE 3.94
  • Revenue
  • OLMA N/A
  • ESE $1,026,759,000.00
  • Revenue This Year
  • OLMA N/A
  • ESE $14.05
  • Revenue Next Year
  • OLMA N/A
  • ESE $11.19
  • P/E Ratio
  • OLMA N/A
  • ESE $34.15
  • Revenue Growth
  • OLMA N/A
  • ESE 7.40
  • 52 Week Low
  • OLMA $5.56
  • ESE $96.69
  • 52 Week High
  • OLMA $16.78
  • ESE $154.00
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 27.35
  • ESE 39.73
  • Support Level
  • OLMA $5.56
  • ESE $133.51
  • Resistance Level
  • OLMA $6.49
  • ESE $137.92
  • Average True Range (ATR)
  • OLMA 0.68
  • ESE 3.06
  • MACD
  • OLMA -0.03
  • ESE -0.88
  • Stochastic Oscillator
  • OLMA 8.41
  • ESE 18.22

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About ESE ESCO Technologies Inc.

ESCO Technologies Inc sells engineered products and systems for utility, industrial, aerospace, and commercial applications. The firm operates in three segments: Aerospace and Defense, Utility Solutions Group (USG), and Test. The Aerospace and Defense segment designs and manufactures specialty filtration and naval products. The USG segment provides diagnostic testing solutions. The Test segment provides its customers with the ability to identify, measure, and contain magnetic, electromagnetic, and acoustic energy.

Share on Social Networks: